The collateral sensitivity to platinum drugs was confirmed when these cell lines were transplanted in vivo.29 However, in the ML017/ET tumour, we found no mutations of these two NER genes and the tumour did not change its low sensitivity to platinum drugs (Supplementary Fig. 3). The gene discussed is NR1H2; the disease is neoplasm.